The cannabis industry is growing, as local initiatives to facilitate medicinal or recreational use expand even in the face of federal resistance. State regulatory regimes are creating a patchwork of experiments that may inform a path forward for a federal regulatory regime, whether or not cannabis is removed from Schedule I of the Controlled Substances Act (CSA).

This year’s Food and Drug Law Journal Symposium considers federal regulation of cannabis, focusing on the Food and Drug Administration (FDA) but also including other federal agencies.  The Symposium will explore the legal and practical implications of current and potential federal regulation on state and local government interests, industry, patients, and consumers. 

Register Now

Industry & Firms

  • $199 for nonmembers


  • $49 for nonmembers


  • $49 for nonmembers


  • $49 for nonmembers


  • full-time students only
Register Now


Preliminary agenda will be announced shortly

Call for Abstracts

FDLI thanks all who participated in the Call for Abstracts.  If you submitted an abstract, you will be notified of the status of your proposal by June 25th.

Continuing Legal Education

FDLI applies for CLE credits in Ohio, Pennsylvania, and Virginia. These CLE approvals may also be honored by other states; please check with your bar association for guidance. The CLE credits will be posted as they are granted and you can request to be notified when approval is received.

Location and Overnight Accommodations


The Symposium will be held near Union Station in Washington, DC. The specific location will be announced in the fall.

Overnight Accommodations

The following hotels are within walking distance of the meeting location:

The Liaison Capitol Hill, 415 New Jersey Ave NW
Hyatt Regency Washington on Capitol Hill, 400 New Jersey Ave NW
Washington Court Hotel, 525 New Jersey Ave NW
Kimpton George Hotel, 15 E St NW

Please contact the Conference Department with any accessibility requirements or dietary restrictions, or for other questions.